Disease & disorder

inflammatory breast carcinoma

MONDO:0006804

An advanced, invasive breast adenocarcinoma characterized by the presence of distinct changes in the overlying skin. These changes include diffuse erythema, edema, peau d'orange (skin of an orange) appearance, tenderness, induration, warmth, enlargement, and in some cases a palpable mass. The skin changes are the consequence of lymphatic obstruction from the underlying invasive breast adenocarcinoma. Microscopically, the dermal lymphatics show prominent infiltration by malignant cells. The invasive breast adenocarcinoma is usually of ductal, NOS type. There is not significant inflammatory cell infiltrate present, despite the name of this carcinoma.

Clinical trials39
Recruiting2
Drug concepts studied20
Synonyms7

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…
Background context

inflammatory breast carcinoma

Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

39 shown
Refining Local-Regional Therapy for IBCNCT04636710 · 2021-06-02
RECRUITING
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast CancerNCT00477100 · 2007-04-17
RECRUITING
Conserving Surgery in Inflammatory Breast Cancer After Neoadjuvant ChemotherapyNCT06131632 · 2024-03-01
NOT_YET_RECRUITING
Onvansertib + Paclitaxel In TNBCNCT05383196 · 2022-09-30
ACTIVE_NOT_RECRUITING
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast CancerNCT05415215 · 2022-07-05
COMPLETED
CAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsNCT04660929 · 2021-02-02
UNKNOWN
Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant ChemotherapyNCT03872388 · 2019-09-23
TERMINATED
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast CancerNCT04030507 · 2019-07-26
ACTIVE_NOT_RECRUITING
Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast CancerNCT03515798 · 2018-08-29
ACTIVE_NOT_RECRUITING
Denosumab as an add-on Neoadjuvant Treatment (GeparX)NCT02682693 · 2017-02-13
COMPLETED
Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast CancerNCT02876107 · 2016-10-06
ACTIVE_NOT_RECRUITING
A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast CancerNCT02623972 · 2016-02-26
ACTIVE_NOT_RECRUITING
Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative ChemotherapyNCT01894451 · 2015-06-01
COMPLETED
A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)NCT02125344 · 2014-12-01
COMPLETED
Laser Optoacoustic and Ultrasonic Imaging System Assembly in Finding Changes in Tumors in Patients With Breast CancerNCT01755130 · 2014-05-13
TERMINATED
Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast CancerNCT01938833 · 2014-04-01
TERMINATED
Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant ChemotherapyNCT02879513 · 2014-01-01
UNKNOWN
Olaparib and Radiotherapy in Inoperable Breast CancerNCT02227082 · 2013-10-21
COMPLETED
Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer PatientsNCT02221999 · 2013-09-01
ACTIVE_NOT_RECRUITING
Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast CancerNCT01730833 · 2013-07-17
COMPLETED
Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast CancerNCT02199418 · 2013-01-01
COMPLETED
Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)NCT01583426 · 2012-07-01
COMPLETED
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast CancerNCT01525966 · 2012-02-15
ACTIVE_NOT_RECRUITING
Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast CancerNCT01426880 · 2011-08-01
COMPLETED
Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast CancerNCT01880385 · 2011-03-01
UNKNOWN
"Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"NCT01641406 · 2011-03-01
UNKNOWN
Accelerated Radiation Therapy After Surgery in Treating Patients With Breast CancerNCT01417286 · 2010-12-21
COMPLETED
MUC1 Vaccine for Triple-negative Breast CancerNCT00986609 · 2009-08-19
COMPLETED
Dose-escalation Study of Oral CX-4945NCT00891280 · 2009-02-01
UNKNOWN
Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer TherapyNCT01038258 · 2007-07-01
UNKNOWN
Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast CancerNCT00513695 · 2007-06-01
COMPLETED
Pilot Study of Inflammatory Breast Cancer in Egypt and TunisiaNCT00344071 · 2004-09-08
COMPLETED
Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast CancerNCT00070252 · 2003-09-01
COMPLETED
Establishing an Inflammatory Breast Cancer RegistryNCT00340158 · 2003-06-01
COMPLETED
Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast CancerNCT00049114 · 2003-02-01
COMPLETED
Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast CancerNCT00016276 · 2001-05-01
TERMINATED
Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast CancerNCT02324088 · 2000-10-01
COMPLETED
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuNCT00004074 · 1999-08-01
COMPLETED
Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast CancerNCT00003199 · 1997-11-01
COMPLETED

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.